Comparing the quality of life of neuropathic patients treated with gabapentin and pregabalin at the neuropathic poly of the NTB provincial hospital in 2019
Author:
Qiyaam Nurul1, Nopitasari Baiq Leny1, Muhajiji Haerul1
Affiliation:
1. Universitas Muhammadiyah Mataram, Indonesia
Abstract
Introduction: Neuropathic pain is caused by the malfunctioning of the central nervous system or the peripheral nervous system. This pain is chronic and so it disrupts a patient’s quality of life which can lead to them becoming frustrated.
Aim: The purpose of this study was to compare the quality of life of neuropathic patients using either gabapentin or pregabalin at the neuropathic clinic of the Regional General Hospital of West Nusa Tenggara Province in 2019.
Methods: This study used a cross-sectional study design. The sampling technique that was used was purposive sampling which was carried out by filling out the EQ-5D-3L and EQ-VAS questionnaires.
Results: The results showed no significant difference between the quality of life of the patients using gabapentin and the patients using pregabalin as the EQ-5D-3L questionnaire had a value of p = 0.683. There was no significant difference between the quality of life between the gabapentin and pregabalin groups using the EQ-VAS questionnaire which had a value of p = 1.000.
Publisher
International Pharmaceutical Federation (FIP)
Subject
Pharmaceutical Science,Pharmacy,Education
Reference16 articles.
1. Annisa, W. R. (n.d.). Penilaian kualitas hidup pada usia lanjut dengan EQ-5D di klub Jantung Sehat Kelurahan Pondok Kelapa dan faktor-faktor yang mempengaruhi = Quality of life using EQ- 5D in elderly joining klub Jantung Sehat Kelurahan Pondok Kelapa and influence factors. 2 2. Argoff, C. E., Backonja, M.-M., Belgrade, M. J., Bennett, G. J., Clark, M. R., Cole, B. E., Fishbain, D. A., Irving, G. A., McCarberg, B. H., & McLean, M. J. (2006). Consensus guidelines: Treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clinic Proceedings, 81(4 Suppl), S12-25. https://doi.org/10.1016/S0025-6196(11)61475-4 3. Backonja, M., Beydoun, A., Edwards, K. R., Schwartz, S. L., Fonseca, V., Hes, M., LaMoreaux, L., & Garofalo, E. (1998). Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA, 280(21), 1831–1836 https://doi.org/10.1001/jama.280.21.1831 4. Boyle, J., Eriksson, M. E. V., Gribble, L., Gouni, R., Johnsen, S., Coppini, D. V., & Kerr, D. (2012). Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care, 35(12), 2451–2458 https://doi.org/10.2337/dc12-0656 5. Centre for Clinical Practice at NICE (UK). (2013). Neuropathic Pain: The Pharmacological Management of Neuropathic Pain in Adults in Non-specialist Settings. National Institute for Health and Care Excellence, (UK). Available at: http://www.ncbi.nlm.nih.gov/books/NBK266257/
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|